Shuaishuai Ge

4PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 12, 2026
Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation.

|Dec 10, 2024
Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.

Meng-Miao Wang, Si-Man Huang, Yuan-Hong Huang

|Jan 18, 2024
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.

Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang

|May 28, 2023
Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy.

Shuai-Shuai Ge, Qiao-Cheng Qiu, Hai-Ping Dai

Pageof 1

Frequent Collaborators

3 joint publications

Hai-Ping Dai

3 joint publications

Sheng-Li Xue

2 joint publications

Qiao-Cheng Qiu

2 joint publications

Song-Bai Liu